By Robert Matone — 2019
Research finds parallels to certain psychoactive drugs.
Read on www.scientificamerican.com
CLEAR ALL
Through this treatment plan, the patient was able to “reconceptualize her trauma” and “was able to move through difficult memories and emotions rather than letting them consume her,” explained U of O associate professor, Monnica Williams.
1
The first randomized controlled trial to compare the illicit psychedelic psilocybin with a conventional selective serotonin reuptake inhibitor (SSRI) antidepressant found that the former improved symptoms of depression just as well on an established metric—and had fewer side effects.
Amazonian healing traditions collide with Western medical sensibilities.
2
To treat depression, the neurons which control the hormones serotonin and dopamine in our brains seem to get all the attention.
The antidepressant effects of the psychedelic brew known as ayahuasca appear to be related to anti-inflammatory activity, according to new research from scientists in Brazil.
In a recent UK trial, 12 patients with major depression took a pill quite different to commonly prescribed antidepressants: 25mg of psilocybin, the psychedelic compound found in magic mushrooms.
At Imperial College we’ve been comparing psilocybin to conventional antidepressants—and the results are likely to be game-changing.